In order to generate coherent biological responses to extracellular stimuli, cells have established synergistic and antagonistic crosstalk between pathways with similar or opposing functions, respectively. Two routes cooperating in the generation of mitogenic and cytoskeletal functions are those induced by Ras and Rho/Rac GTPases. In these signaling interactions, Rho/Rac proteins have been always placed in a downstream position respect to Ras in all cell systems analysed so far. In this report, we describe that such signaling hierarchy does not apply to T-lymphocytes. Thus, we show that both Rac1 GDP/GTP exchange factors such as Vav and constitutively active versions of Rac1 can promote the effective stimulation of the Ras pathway in T-lymphocytes. The molecular link for this new type of pathway interconnectivity is RasGRP1, a diacylglyceroldependent GDP/GTP exchange factor for Ras that translocates to the plasma membrane in a Vav-and Rac1-dependent manner. The effect of the Vav/Rac1 pathway on the Ras pathway is highly dependent on the activity of phospholipase C-c, the key cellular supplier of intracellular diacylglycerol. Signaling experiments suggest that this crosstalk represents a signaling strategy used by the T-cell receptor to promote robust biological responses of both the Rac/Rho and Ras pathways upon antigen engagement.
Introduction
One frequent event in the signaling pathways engaged by extracellular factors and antigens is the activation of GTPases of the Ras and Rho/Rac subfamilies (Lowy and Willumsen, 1993; Pronk and Bos, 1994; Boettner and Van Aelst, 2002; Etienne-Manneville and Hall, 2002) . These GTPases share a common regulatory cycle that depends on the binding of guanosine nucleotides (Lowy and Willumsen, 1993; Pronk and Bos, 1994; Boettner and Van Aelst, 2002; Etienne-Manneville and Hall, 2002) . In nonactivated cells, these GTPases are found in a GDP-bound, inactive state. The stimulation of membrane receptors leads to the release of GDP and the incorporation of GTP molecules, a step catalysed by a diverse group of enzymes usually known as guanosine nucleotide exchange factors (GEFs) or GDP releasing proteins (GRPs) (Overbeck et al., 1995; Zheng, 2001 ). This exchange of nucleotides induces a conformational change in the GTPases that converts them in optimal docking sites for effector molecules (Lowy and Willumsen, 1993; Pronk and Bos, 1994; Boettner and Van Aelst, 2002; Etienne-Manneville and Hall, 2002) . The stimulatory window of these GTPases is subsequently shut off by the hydrolysis of the bound GTP, a step mediated by GTPase-activating proteins (GAPs) (Lowy and Willumsen, 1993; Pronk and Bos, 1994; Boettner and Van Aelst, 2002; Etienne-Manneville and Hall, 2002) . As in most cell types, Ras and Rho/Rac proteins both play critical roles in the development and signaling capabilities of T cells (Bustelo, 2002a, b; Cantrell, 2003) . Perhaps the best examples for such implication are the genetic studies performed with RasGRP1 and Vav, two oncogenic GEFs specific for Ras/Rap and Rac/ RhoA proteins respectively (Ebinu et al., 1998 Bustelo, 2000; Hogquist, 2001) . RasGRP1, also known as calcium-and diacylglycerol-dependent GEF-II (CalDAG-GEF-II), is a Ras/Rap GEF whose biological activity is dependent on diacylglycerol (DAG) (Ebinu et al., 1998 Hogquist, 2001) , one of the second messengers generated by the enzyme activity of phospholipase C (PLC)-g. The deletion of the rasgrp1 locus in mice results in abnormal thymocyte differentiation, leading to very reduced numbers of mature T-lymphocytes of both helper and cytotoxic lineages (Dower et al., 2000; Priatel et al., 2002) . In addition, the proliferation of thymocytes after T-cell receptor (TCR) stimulation is impaired (Dower et al., 2000) . A spontaneous null mutation found for RasGRP1 in a strain of mice revealed additionally a role for this GEF in the maintenance of T-cell tolerance and homeostasis (Layer et al., 2003) . The lack of RasGRP1 expression is associated with the inability of these cells to induce the stimulation of the Ras pathway upon treatment with either phorbol esters or antibodies to the TCR (Dower et al., 2000; Hogquist, 2001) . Vav is a phosphorylation-dependent GEF that facilitates GDP release from Rac and RhoA proteins (Bustelo, 2000) . The deletion of the vav proto-oncogene in mice results in very similar phenotypes to those described for rasgrp1 (À/À) mice, including an unexpected reduction in Erk activation upon TCR engagement (Costello et al., 1999; Turner and Billadeau, 2002) . It also impairs the normal activation of PLC-g1, leading to the generation of low calcium fluxes upon TCR engagement (Costello et al., 1999; Turner and Billadeau, 2002) . According to its role as Rac1 GEF, vav (À/À) T cells also show severe defects in cytoskeletal organization that result in the abnormal formation of lipid rafts and immune synapses (Turner and Billadeau, 2002) .
In addition to the engagement of their specific downstream elements, it has become clear during these last years that the pathways of the Ras and Rho/Rac subfamilies are closely intertwined through diverse signaling crosstalk (Bar-Sagi and Hall, 2000) . For instance, it has been shown that PAK, a Rac1 effector with serine/threonine kinase activity, can contribute to the upregulation on the Ras pathway via the phosphorylation of two Ras downstream elements, Raf and MEK1 (Bar-Sagi and Hall, 2000) . Conversely, Akt, a Ras downstream element whose activity is dependent on phosphatidylinositol 3-kinase (PI3-K) activity, has been shown to promote the phosphorylation of PAK in some cellular contexts (Bar-Sagi and Hall, 2000) . Another set of interactions between these two pathways is due to the direct activation of Rho/Rac GEFs by either Ras or some of its downstream elements. Thus, it has been demonstrated that active Ras can associate physically with Tiam1, a Rac1-specific GEF (Lambert et al., 2002) . In addition, Ras can upregulate the exchange activity of several exchange factors for Rac1 such as Tiam1, Vav, and Sos1 via one of its main effectors, PI3-K ( Bar-Sagi and Hall, 2000) . Despite these advances in the GTPase field, the signaling relationships between the Ras and the Rho/Rac pathways in T-lymphocytes have not been fully explored as yet. Early studies have indicated that Ras and Rho/Rac proteins appear to be independent in T-lymphocytes (Bar-Sagi and Hall, 2000) . However, more recent evidence using either primary T-lymphocytes or transformed T-cell lines suggests otherwise. For instance, as indicated above, Vav proteins appear to contribute to the activation of Erk in T cells despite the fact that they are not GEFs for Ras (Bustelo, 2000; Turner and Billadeau, 2002) . Likewise, Vav can trigger the induction of Rasdependent responses when overexpressed in Jurkat cells (Villalba et al., 2000b) . These effects appear to be Rac dependent, since rac2 (À/À) T cells also have some defects in Erk activation (Yu et al., 2001) . Despite this evidence, the mechanism that mediates the interconnection between the Vav/Rac pathways and the Ras route in T cells remains unknown up to know. To clarify this point, we have evaluated the interactions of Vav and Rac1 with the Ras pathway in Jurkat cells. Our results indicate that T cells use a strategy to interconnect these two pathways that is totally different from those described before for nonlymphoid cells. This link is established through a Vav-and Rac-dependent increase in the translocation and phosphorylation level of PLC-g1 that, in turn, favors the activation of RasGRP1.
Results
The Vav/Rac pathway cooperates with RasGRP1 for optimal activation of Ras To start dissecting the signaling relationships between the Vav/Rac and Ras pathways during T-cell stimulation, we made use of previous observations with knockout animals demonstrating that the disruption of vav and rac2 genes affects negatively the activation of PLC-g (Costello et al., 1999; Yu et al., 2001) . Moreover, we and others have observed that, in vav3 (À/À) chicken B cells, there is no proper stimulation of the Ras pathway upon B-cell receptor activation, a defective response derived from defective PLC-g activation (Inabe et al., 2002; Caloca et al., 2003b) . These observations prompted us to investigate whether Vav could influence the activation status of the Ras pathway in T cells via the stimulation of RasGRP1, a Ras/Rap-specific GEF whose activity is strictly dependent on DAG (Lorenzo et al., 2000) . To this end, we expressed wild-type H-Ras (HA-tagged) in Jurkat cells alone or with the appropriate combinations of RasGRP1, Vav, and the Vav oncoprotein (D1-66 mutant). RasGRP1 was expressed at suboptimal concentrations in these transfections to facilitate the readouts of the subsequent experiments. The levels of activated H-Ras were then evaluated using pull-down experiments with a GST protein fused to the c-Raf1 Ras binding domain (RBD). These experiments indicated that the coexpression of Vav or Vav (D1-66) with RasGRP1 results in higher levels of H-Ras activation than when this Ras GEF is expressed alone (Figure 1a , compare lanes 5 and 6 with lane 4). A similar synergism was observed when Vav was replaced in these transfections by the constitutively active version of Rac1 (Q61L mutant) (Figure 1b) , suggesting that the Vav/ RasGRP1 crosstalk is mediated by the main Vav effector and not by Rac1-independent routes. Immunoblot experiments confirmed that all proteins were properly expressed (Figure 1a ,b, lower panels).
To further characterize this functional interaction, we investigated the effect of Vav and Rac1 on the subcellular localization of RasGRP1. To this end, we expressed in Jurkat cells a FLAG-tagged version of RasGRP1 alone or in combination with the activated versions of either Vav (D1-186 mutant) or Rac1 (Q61L mutant). To facilitate these experiments, these two proteins were expressed fused to the C-terminus of the enhanced green fluorescent protein (EGFP). After expression, the cells were stained with anti-FLAG antibodies to visualize RasGRP1. Since it has been previously shown that RasGRP1 only gets activated in the Golgi apparatus in Jurkat cells (Bivona et al., 2003) , we also performed co-staining experiments with antibodies to GM130, a protein localized exclusively in this cellular organelle (Caloca et al., 2003a) . The visualization of the stained cells by confocal microscopy revealed that RasGRP1 is distributed exclusively in the cytoplasm in the absence of stimulation (Figure 2A , panels a and c; Figure 2B Figure 2A , compare panels e and f, i and j), suggesting that RasGRP1 is localized exclusively at the plasma membrane under these particular conditions. The translocation of RasGRP1 induced by Vav and Rac1 is similar to that promoted by the TCR upon exposure of cells to anti-CD3 antibodies ( Figure 2B ). However, RasGRP1 shows usually in the latter case a more polarized migration, concentrating specifically in caplike structures ( Figure 2B ). As above, RasGRP1 was not detected in the Golgi apparatus under these stimulation conditions, suggesting that the main target of this GEF during early TCR stimulation times is the membranelocalized Ras protein. This behavior is similar to the translocation of RasGRP1 described by us in nonlymphoid cells (Caloca et al., 2003a) .
The action of Vav and Rac1 proteins on RasGRP1 is specifically dependent on PLC-g activity
To test whether the action of Vav and Rac1 on RasGRP1 was due to increased levels of PLC-g activity, Q61L (panels h-k) were attached to coverslips, fixed, and incubated with rabbit anti-FLAG (panels ak) and mouse anti-GM130 (panels a-k) antibodies followed by Cy5-and Cy3-labeled antibodies to rabbit and mouse IgGs, respectively. After immunostaining, cells were analysed by confocal microscopy. Images show in green, blue, and red the localization of the EGFP, RasGRP1, and GM130 proteins, respectively. (B) Subcellular localization of RasGRP1 in nonstimulated and TCRstimulated Jurkat cells. Cells expressing an EGFP-tagged version of RasGRP1 were stimulated with anti-CD3 antibodies (2 mg/ml) during the indicated periods of time, fixed, and subjected to confocal microscopy Vav-dependent activation of Ras via RasGRP1 JL Zugaza et al we examined the effect of specific inhibitors for this enzyme on this biological response. To this end, Jurkat cells were transfected with H-Ras, RasGRP1, and Vav in the appropriate combinations and, after an overnight culture, were either left untreated or treated for 1 h with the PLC inhibitor U73122 (Vassilopoulos et al., 1995) .
As negative control, we utilized a U73122 analog (U73343) that does not have any effect on the catalytic activity of PLC-g (Vassilopoulos et al., 1995) . As shown in Figure 3a , the incubation of cells with U73122 totally abolishes the Vav/RasGRP1-dependent activation of HRas (upper panel, compare lanes 4 and 6). In contrast, Figure 3 The effect of the Vav/Rac pathway on RasGRP1 is dependent on the activity of PLC-g. (a, b) Jurkat cells expressing HA-HRas with the indicated combinations of RasGRP1 (a, b), Vav (a), or Rac1 (b) proteins were either left untreated or treated for 1 h at 371C with the indicated chemicals (Alexia Biochemicals, 10 mM each). After these incubations, the levels of GTP-H-Ras in each condition were evaluated using GST-RBD pull-down experiments followed by immunoblots with anti-HA antibodies (upper panel). As control, cell lysates obtained from the same experiment were blotted with anti-HA (a, b, middle panel), anti-Vav (a, lower panel), or anti-AU5 (b, lower panel) antibodies to visualize the levels of expression of H-Ras (a, b), Vav (a), and Rac1 (b) in each experimental sample. The migration of the expressed proteins is indicated by arrows. (c) Untransfected Jurkat T cells were pretreated with the indicated drugs (bottom) as indicated above. Cells were left unstimulated (À) or were stimulated with anti-CD3 antibodies and lysed. The cell lysates obtained were then subjected to immunoblot analysis using the indicated antibodies (right side) to detect the levels of phosphorylated Erk1 (upper panel), total Erk1 (second panel from top), phosphorylated PKD (third panel from top), and total PKD (lower panel). The mobility of each of these proteins is indicated by arrowheads. (d, e) Jurkat cells expressing HA-H-Ras with the indicated combinations of RasGRP1 (d-e), Vav (d), and Rac1 (e) proteins were either left untreated or treated for 1 h at 371C with inhibitors specific for PI3-K (wortmannin, Sigma, 100 nM) and PKC (GF109203X, Calbiochem, 3.5 mM). After these incubations, the levels of GTP-H-Ras in each condition were evaluated as indicated in (a). As control, cell lysates obtained from the same experiment were blotted with anti-HA (d, e, middle panel), anti-Vav (d, lower panel), or anti-Rac1 (e, lower panel) antibodies to visualize the levels of expression of H-Ras (d, e), Vav (d), and Rac1 (e) in each condition. The migration of the ectopically and endogenously expressed proteins is indicated by black and white arrows, respectively. (f) Untransfected Jurkat cells were pretreated with the indicated drugs (bottom) as indicated above. Cells were then left unstimulated (À) or stimulated with anti-CD3 antibodies as in (c). Protein lysates derived from these cells were subjected to immunoblot analysis using the indicated antibodies (right side) to detect the levels of phosphorylated PKD (upper panel), total PKD (second panel from top), phosphorylated Akt (third panel from top), and total Akt (lower panel). The mobility of each of these proteins is indicated by arrowheads the U73343 compound has no detectable effect on this cellular response (Figure 3a , upper panel, compare lanes 5 and 6). Immunoblot analysis indicated that both HRas and Vav were expressed under these culturing conditions ( Figure 3a , middle and lower panels, respectively). Similar results were obtained when the effect of these two compounds was studied in the Rac1-dependent activation of RasGRP1 (Figure 3b) . As positive control, we analysed the influence of U73122 and U73343 on the activation of Erk and protein kinase (PK) D since it has been shown that the activation of these kinases in T cells is either totally (Erk) or partially (PKD) DAG dependent Matthews et al., 2000) . In agreement with these observations, we found that U73122 induces an inhibition of approximately 100 and 75% in the phosphorylation levels of Erk1 and PKD, respectively (Figure 3c ). Taken together, these results indicate that Vav and Rac1 use PLC-g as the main linker to connect with RasGRP1.
Given that DAG has pleiotropic effects on T cells, we took into consideration the possibility that the inhibition of DAG production by U73122 could have indirect, RasGRP1-independent effects on the Ras pathway. In support of this possibility, it had been proposed that PKC can upregulate the Ras route in T cells (Ohtsuka et al., 1996) . Moreover, it has been recently demonstrated that PKC can phosphorylate another RasGRP family member (RasGRP3) during the stimulation of the B-cell receptor (Teixeira et al., 2003) . In the same functional context, the reports indicating that Vav could activate PKCy (Villalba et al., 2000a) constituted additional points of concern to us. Owing to this, we decided to evaluate the actual contribution of PKCs to the Vav/Rac1-mediated activation of RasGRP1 by using a specific inhibitor of PKCs (GF109203X) (Toullec et al., 1991) . Unlike the effects induced by the PLC-g inhibitor, we found that the inhibition of PKC in Jurkat cells has no consequences for the activation of RasGRP1 by either Vav (Figure 3d , upper panel, compare lanes 4 and 5) or Rac1 Q61L (Figure 3e , upper panel, compare lanes 4 and 5). Moreover, GF109203X has neutral influence on the TCR-dependent stimulation of Erk in Jurkat cells (data not shown), further suggesting that the PKC pathway does not play any active role in the modulation of the Ras pathway in Jurkat cells. As expected (Matthews et al., 2000) , GF109203X totally abrogates the TCRdependent phosphorylation of PKD (Figure 3f , upper panel, compare lanes 2 and 3), indicating that the lack of effect of this compound in the previous experiments was not due to improper conditions of use. Taken together, these results further confirm that Vav and Rac1, via PLC-g, trigger the direct activation of RasGRP1. Moreover, this biological response is totally independent of the activity of PKCs.
The effect of the Vav/Rac pathway on RasGRP1 is independent of the kinase activity of PI3-K Previous results have indicated that PI3-K has a major role in the activation of PLC-g in immature T cells (Reynolds et al., 2002) . Since the PI3-K pathway is constitutively active in Jurkat cells due to a null mutation in the pten gene (Shan et al., 2000) , our previous experiments could not exclude the participation of PI3-K-dependent pathways in the activation of RasGRP1 by either Vav or Rac1. To evaluate this possibility, we checked the effect of PI3-K on the Vav/ Rac1-dependent activation of RasGRP1 by culturing cells with wortmannin, an effective chemical inhibitor of this lipid kinase (Powis et al., 1994) . These experiments indicated that this compound has no detectable effect on the activation of RasGRP1 by either Vav (Figure 3d To test the mechanism by which Vav and Rac1 promote the activation of PLC-g, we first studied their possible effects on the tyrosine phosphorylation of this enzyme. To this end, we transfected Jurkat cells with an HAtagged version of PLC-g1 alone or in combination with Vav (D1-66). To measure the phosphorylation status of PLC-g1, cell lysates from those transfections were immunoprecipitated with anti-HA antibodies and subjected to immunoblot analysis with an antibody to a key phosphorylation site (Y783) of PLC-g1 (Kim et al., 1991) . These experiments indicated that PLC-g1 is poorly phosphorylated in nonstimulated cells when expressed alone (Figure 4a, upper panel, lane 1) . However, the stimulation of Jurkat cells with anti-CD3 antibodies induces the rapid phosphorylation of PLC-g1 (Figure 4a, upper panel, compare lanes 1 and 2) . Likewise, the expression of Vav (D1-66) triggers the phosphorylation of PLC-g1 independently of upstream signals from the TCR (Figure 4a , upper panel, compare lanes 1 and 4). This effect is dependent on Rac1, since a catalytically inactive version of Vav (D1-66 þ L213Q mutant) cannot induce the same effect (Figure 4a , upper panel, compare lanes 3 and 4). The analysis of cell extracts from the same experiments by Western blot analysis confirmed that both PLC-g1 and Vav proteins were expressed at comparable levels in all samples (Figure 4a , middle and lower panels, respectively). The implication of Rac1 in this response was further verified by a similar set of experiments in which Vav (D1-66) was replaced by either the wild type or constitutively active forms of Rac1. As shown in Figure 4b , Rac1 Q61L can mimic the effect of Vav (D1-66) in promoting the TCRindependent phosphorylation of PLC-g1 on tyrosine residue 783 (Figure 4b , upper panel, compare lane 1 with lanes 5 and 6). In contrast, wild-type Rac1 is inactive in this response (Figure 4b , upper level, compare lanes 1 and 4) despite being expressed at significantly higher levels than the Rac1 Q61L version (Figure 4b , lower panel, compare lane 4 with lanes 5 and 6). This is probably due to the preferential loading of wild-type Rac1 with GDP in nonstimulated cells (data not shown). To further dissect this signaling response, we evaluated the effect of the three known effector mutants of Rac1
, and Rac1
activates PAK and JNK but cannot trigger cytoskeletal change or cell transformation. Rac1 Q61L þ Y40C can induce cytoskeletal changes and tumorigenesis without detectable activation of PAK and JNK. Lastly, the Rac1 mutant protein lacking the a3 0 insert region (Rac1 G12V þ DIns ) can activate JNK, PAK, and cytoskeletal change but cannot trigger superoxide production in cells. As a consequence, this mutant GTPase cannot elicit cell transformation when expressed in cells (Joneson et al., 1996; Joneson and Bar-Sagi, 1998 5 and 6 ). These results indicate that the Rac1-dependent phosphorylation of PLC-g1 is probably associated with cytoskeletal events and uncoupled from other Rac1-dependent pathways such as those induced by PAK, JNK, or superoxide molecules.
Since PLC-g1 phosphorylation usually correlates with its translocation to the plasma membrane (Wang et al., 2001) , we decided to test the effect of Vav on the subcellular localization of this enzyme. To this end, Jurkat cells expressing HA-tagged PLC-g1 with or without Vav were lysed in the absence of detergents and the postnuclear supernatants were subjected to centrifugation to purify the cytosolic and membrane fractions. The distribution of HA-PLC-g1 in these fractions was subsequently evaluated by Western blot analysis with anti-HA antibodies. These experiments indicated that the coexpression of Vav (D1-66) with PLC-g1 results in a fivefold increase in the levels of PLCg1 present in the membrane fractions (Figure 5a , upper panel, compare lanes 3 and 5). As a control for the quality of the fractionation, we utilized aliquots of the same cellular extracts to study the distribution of endogenous markers for the membrane and cytosolic fractions. The protein tyrosine kinase Lck was found exclusively in the membrane fraction in all conditions used (Figure 5a , second panel from top, compare lanes 1 and 2, 3 and 4, or 5 and 6). g-Tubulin was localized Parallel aliquots of cell lysates were subjected to Western blot analysis with either anti-HA (a-c, middle panels), anti-Vav (a, lower panel), or anti-Rac1 (b, c, lower panels) antibodies to detect the expression of these proteins. As additional control (a-c, lanes 1 and 2), we included samples obtained from PLC-g1-expressing cells that were either nonstimulated (À) or stimulated ( þ ) with anti-CD3 antibodies. The mobility of the endogenously and ectopically expressed proteins is indicated by white and black arrows, respectively indistinctly in both the cytosolic-and membraneenriched fractions (Figure 5a, lower panel) . Similar results were obtained when Vav was substituted by Rac1 Q61L in these experiments (Figure 5c, upper panel) . Western blot analysis of the total cellular lysates before the centrifugation step indicated that PLC-g1, Vav, and Rac1 were expressed in the expected samples (Figure 5b and d). Taken collectively, these results indicate that the Vav/Rac1 pathway has a direct effect on the subcellular localization and phosphorylation levels of PLC-g1 that probably results in high levels of enzyme activity.
The interaction between Vav and RasGRP1 results in enhanced activation of Ras-and Rac-dependent biological responses
To evaluate the functional consequences of the interaction between Vav and RasGRP1, we finally analysed whether the simultaneous engagement of these two molecules could induce more robust Ras-and Rac1-dependent biological responses in T cells. To this end, we first measured the effect of overexpressing Vav on the levels of activation of Erk1, one of the main signaling branches of the Ras pathway. To this end, we electroporated Jurkat cells with the appropriate combinations of plasmids encoding HA-Erk1, RasGRP1 (suboptimal concentrations), and/or wild-type Vav. The activity of the ectopically expressed Erk1 was subsequently determined by immunocomplex kinase assays. The coexpression of wild-type Vav and RasGRP1 in Jurkat cells results in higher levels of activation of Erk when compared with transfections using each signaling molecule alone (Figure 6a , compare lane 4 with lanes 2 and 3). To see whether the RasGRP1 pathway could also cooperate in inducing higher activation levels of the Vav pathway in T cells, we utilized transient transactivation assays to measure the effect of RasGRP1 on the Vav-dependent activation of the nuclear factor of activated T cells (NF-AT) (Bustelo, 2000) . As shown in Figure 6b , the expression of either Vav (in suboptimal conditions) or RasGRP1 proteins in Jurkat cells results in low levels of NF-AT activation (bars 2 and 4, respectively). In contrast, the coexpression of these two signaling proteins promotes a synergistic response that induces higher levels of NF-AT activation (Figure 6b , bar 6). This effect is specific for RasGRP1, because another Ras GEF (Sos1) does not cooperate with Vav under the same experimental conditions (Figure 6b , 
Discussion
All stimulatory interactions described to date between the Ras and Rac1 pathways always have the Ras GTPase in an upstream position over Rac1 (Bar-Sagi and Hall, 2000) . The mechanisms by which Ras can influence the activation status of Rho/Rac GTPases are quite diverse. In some cases, Ras can induce the expression of genes encoding upstream regulators of Rho/Rac proteins such as GEF-H1 (Zuber et al., 2000) . Ras can also associate physically with Rac1 GEFs (i.e., Tiam1) (Lambert et al., 2002) . Finally, Ras can activate indirectly Rac1 GEFs through the PI3-K-dependent increase in the levels of phosphatidylinositol triphosphate. This regulation has been described for several Rac1 GEFs such as Vav, Sos1, Dbl, and Tiam1 (Bar-Sagi and Hall, 2000) . The interaction of Ras with Rho/Rac GEFs is a signaling strategy that appears to have been set up very early in evolution, since examples can be found even in unicellular eucaryotes (Bar-Sagi and Hall, 2000) . Here we have presented evidence indicating that a different signaling hierarchy is operational in T-lymphocytes. Thus, we have shown using gain-of-function experiments that Vav and Rac1 can promote the activation of H-Ras via the stimulation of RasGRP1, a DAG-dependent GEF specific for GTPases of the Ras subfamily. The strategy used by the Rac1 pathway for the activation of Ras relies on a complex signaling crosstalk that involves the modulation of the activity of PLC-g through increased membrane translocation and tyrosine phosphorylation. This new pathway interconnection is supported by several experimental observations, including the higher activity of RasGRP1 in the presence of Vav or Rac1 Q61L , the translocation of RasGRP1 from the cytosol to the plasma membrane in the presence of either Vav or Rac1 Q61L , the specific abolition of the Vav/Rac1-dependent activation of RasGRP1 by inhibitors of PLC-g, and the increased phosphorylation and translocation of PLC-g upon the expression in Jurkat cells of either Vav or Rac1
Q61L
. The direct implication of PLC-g in this process is further substantiated by our observations demonstrating that the inhibition of DAG-responsive proteins such as PKC has no effect on the activation of the Ras pathway in both TCR-stimulated and Vav/Rac1 Q61L -expressing Jurkat cells. These results, coupled with our previous observations in chicken B cells (Caloca et al., 2003b) , point toward a general implication of the Vav/Rac pathway in the stimulation of Ras in all lymphocyte lineages. However, since mouse vav (À/À)/vav2 (À/À)/ vav3 (À/À) triple knockout B cells do not show any detectable defect in Erk activation (Fujikawa et al., 2003) , these observations indicate that in mammalian systems the activation of Ras in B cells will be more complex than in T cells. This may be due to the different RasGRP family member expressed in B cells (RasGRP3) (Teixeira et al., 2003) or, alternatively, to a more direct implication of the Grb2/Sos pathway in the B-cell receptor pathways that lead to Ras activation. Further experiments should be carried out to address the signaling particularities of the RasGRP family pathway in this and other cell systems.
In our opinion, the new Rac-Ras interconnection described here may help clarifying several puzzling observations made in both the Vav and TCR signaling fields that have not been fully explained up to now. Thus, it has been shown that the overexpression of Ras dominant-negative mutants inhibits certain Vav-dependent responses (Wu et al., 1995) . The reason for this action was always unclear, since this negative mutant could not interfere with Vav or its downstream elements. These observations can be rationalized now if we consider the RasGRP1/Ras pathway as another downstream branch of the Vav/Rac1 pathway in T-lymphocytes. As such, the high binding affinity of the Ras Values were normalized using the renilla readout of each sample and represent the mean and standard deviation of four independent experiments, each performed in duplicate dominant-negative mutant to RasGRP1 would result in the inhibition of Ras activation, leading indirectly to the impairment of the biological responses induced by Vav that are RasGRP1/Ras dependent. It has also been observed that the elimination of vav family protooncogenes in T cells results in the attenuation of Erk stimulation upon TCR engagement (Costello et al., 1999; Fujikawa et al., 2003) . This defective response can be now attributed to the lack of normal RasGRP1 activation in Vav-deficient T-lymphocytes. Our observations indicating that Vav can activate PLC-g also suggest that the low levels of PLC-g activity in vav (À/À) T cells are a direct consequence of the absence of Vav and not a by-product of the abnormal assembly of the cytoskeleton or the immune synapse of vav (À/À) T cells (Turner and Billadeau, 2002) .
It is tempting to speculate that the crosstalk described here may contribute to the amplification of TCR signals by two independent avenues: branching of upstream signals (signaling divergence) and setting up of selfupregulatory mechanisms. The upregulation of PLC-g activity by Vav or Rac1 during signal transduction is a clear source of signaling divergence since it may result in the engagement of many other pathways outside the Rac1 and Ras realms. In this respect, previous studies have shown already that PKCy is indeed activated by Vav in T cells (Villalba et al., 2000a) . Although initial reports suggested that such effect was independent of DAG (Villalba et al., 2000a (Villalba et al., , 2002 , more careful observations published later on indicated that PLC-g was essential in this process (Diaz-Flores et al., 2003) . PKD is another possible target for increasing the diversity of downstream effects of the Vav pathway, since its activation during T-cell and B-cell receptor signaling requires the cooperation of PLC-g activity (Matthews et al., 2000) . In agreement with this possibility, preliminary experiments conducted in our laboratory indicate that the phosphorylation of PKD is severely impaired in the absence of Vav function (JL Zugaza and XR Bustelo, unpublished observations). Given previous results indicating that Ras can upregulate Vav via PI-3K (Bar-Sagi and Hall, 2000) , the Vav/ Rac-RasGRP1 crosstalk described here represents also an obvious self-amplifying relay mechanism that could allow the assembly of robust T-cell signaling responses through the bidirectional and reciprocal enhancement of Rac-and Ras-dependent pathways.
Materials and methods

Tissue culture and DNA transfections
Jurkat T cells were cultured as previously described (LopezLago et al., 2000) . For ectopic expression of proteins, exponentially growing cell cultures were harvested, resuspended in 400 ml of RPMI-1640 to a final concentration of 5 Â 10 7 cells/ml and electroporated (250 V and 960 mF) with the appropriate plasmids. For GTP-Ras pull-down experiments, the amounts of expression vectors used in transfections were 50 ng for plasmids encoding FLAG-RasGRP1 proteins, 5 mg for vectors encoding HA-H-Ras, and 25 mg for plasmids containing Vav or Rac1 proteins. For PLC-g1-related assays, cells were electroporated with 5 mg of a plasmid encoding HAPLCg1 either alone or in combination with 40 mg of the other vectors. For luciferase NF-AT assays, cells were electroporated with pNF-AT/luc and pSRL-SV40 (5 mg each) alone or in combination with plasmids encoding Vav (2.5 mg), RasGRP1 (15 mg), and/or Sos1 (15 mg). For in vitro Erk1 kinase assays, cells were transfected with plasmids encoding HA-Erk1 (5 mg), RasGRP1 (50 ng), and/or Vav (25 mg) in the appropriate combinations. When necessary, transfections were supplemented with empty vectors to normalize the amount of transfected DNA per sample. After electroporation, cells were diluted in RPMI-1640 containing 10% fetal bovine serum and cultured for 18 h at 371C and 5% CO 2 . When necessary, Jurkat cells were stimulated with anti-CD3 antibodies (10 mg/ml, Dako) for 5 min at room temperature. For immunofluorescence studies, Jurkat T cells were transfected with liposomes (X-tremeGENE Q2, Roche Molecular Biochemicals) according to the manufacturer's instructions. In this case, cells were transfected with 1 mg of vectors encoding RasGRP1 plus 2 mg of plasmids encoding EGFPtagged molecules.
Immunoblotting
For the detection of all proteins except Vav (D1-66), equal amounts of total cellular lysates in RIPA buffer were diluted 1 : 1 with 2 Â SDS-PAGE sample buffer. In the case of Vav (D1-66), we used RIPA buffer supplemented with 1% SDS to disrupt the cells or, alternatively, we resuspended the insoluble postcentrifugation pellet by boiling in 2 Â SDS-PAGE sample buffer. This is due to the insolubility of this protein in nondenaturing conditions (Kranewitter and Gimona, 1999) . Extracts were then separated electrophoretically and transferred to nitrocellulose filters (Schleicher and Schuell). After standard incubations with the appropriate antibodies, the immunoreactive bands were visualized using a commercial chemiluminescence detection system (ECL/Plus, Amersham Biosciences). Primary antibodies were obtained from Covance (anti-HA, anti-AU5), Upstate Biotechnology (anti-Rac1), Cell Signaling Technology (antibodies to phosphoErk, Erk, phosphoPKD, PKD, and phosphoPLCg1), Sigma (anti-g-tubulin), and Santa Cruz Biotechnology (anti-Lck). Rabbit antibodies to the Vav DH were developed in our laboratory using a GST-DH protein as immunogen.
Immunofluorescence
At 24 h after transfection, cells were transferred to polylysinecoated coverslips and allowed to attach for 30 min. Cells were fixed with formaldehyde (Sigma) and subjected to immunostaining. Immunological reagents used were anti-FLAG M2 (Sigma), anti-GM130 (BD Transduction Laboratories), and Cy3-and Cy5-labeled anti-IgG antibodies (Jackson Immunolabs). Cells were analysed with a laser scanning confocal microscope (LSM 510, Zeiss). Final processing of images was carried out with the Adobe Photoshop (Adobe Systems) program.
Ras pathway assays
GTP-levels of Ras were determined using GST-c-Raf1-RBD binding experiments, as previously described (Caloca et al., 2003a) . Activation of Erk was monitored by using phosphospecific antibodies or by immunocomplex kinase assays (Crespo et al., 1996) .
Subcellular fractionation
Transfected Jurkat cells were lysed in a hypotonic buffer (20 mM Tris-HCl (pH 7.6), 2 mM EDTA, 3 mM benzamidine, 1 mM Na 3 VO 4 , 1 mM PMSF, 10 mg/ml leupeptin, and 10 U/ml aprotinin) and disrupted by passing the cell suspensions 10 times through a 0.5 Â 25 mm needle. After removal of nuclei by centrifugation (300 g for 10 min at 41C), particulate and soluble fractions were separated by centrifugation (12 000 g for 15 min at 41C) and subjected to immunoblot analysis using appropriate antibodies.
Luciferase assays
Transfected Jurkat cells were lysed (Lopez-Lago et al., 2000) and levels of luciferase and renilla were activity evaluated using the Dual Luciferase Reporter System (Promega) according to the supplier's specifications.
